Skip Navigation

European Heart Journal 1994 15(Supplement C):34-48; doi:10.1093/eurheartj/15.suppl_C.34
Copyright © 1994 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Vester, E. G.
Right arrow Articles by Strauer, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vester, E. G.
Right arrow Articles by Strauer, B. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 The European Society of Cardiology

Ventricular Late Potentials: State of the Art and Future Perspectives

E. G. Vester and B. E. Strauer

Department of Internal Medicine/Cardiology of the Heinrich Heine University Düsseldorf, Germany

Correspondence: Ernst Günter Vester, MD Medizinische Klinik und Poliklinik B, Abteilung für Kardiologie, Pneumologie und Angiolgie, der Heinrich-Heine-Universität Düsseldorf, Moorenstr. 5, D-40225 Düsseldorf, Germany

Although the signal-averaging technique is over one hundred years old, its first use was demonstrated on the human heart in 1963 and ten years later recording of His bundle potentials from the body surface became feasible. During the last decade interest has been focused on ventricular late potentials (L P) which represent zones of delayed myocardial activation occurring in hearts after myocardial infarction as well as in diffusely damaged myocardium. Presentation of LP in the ‘time domain analysis’ is highly standardized and widely accepted. Development of spectral analysis techniques is still advancing and promises not only a more sophisticated interpretation of LP but also detection of electrical disturbances during the whole QRS complex.

In clinical cardiology LP are found in 10% to 50% of all cardiac diseases mainly in coronary heart disease and dilated cardiomyopathy. About 80% of patients with sustained ventricular tachyarrhythmia demonstrate LR. Their value as predictive of arrhythmic events and sudden cardiac death is relatively low (10–30%), but very high in predicting a good outcome, showing 95% event free survival if LP are negative. Predictive accuracy can be enhanced by a combination of independent indices, particularly heart rate variability. Other clinical applications are prediction of patency of the infarct-related artery after thrombolysis or after angioplasty in acute myocardial infarction and prediction of success after guided anti-tachycardiac surgery. No consistent changes can be observed following elective revascularization by angioplastry or bypass surgery. Ischemia, exercise and manipulation of autonomic tone apparently do not consistently influence LP if ensemble signal-averaging is applied, but may cause transient alterations detectable by beat-to-beat analysis.

Potential future directions are (1) evaluation of spectral analysis techniques, (2) improvement of the predictive value by combining time and frequency domain analysis, (3) increased application of beat-to-beat analysis in different pathophysiological conditions, (4) enhanced diagnosis of high-risk patients by combining other independent arrhythmic indices with LP, (5) specific selection of patients for invasive electrophysiological testing and (6) the study of LP shifting during long-term therapy of heart hypertrophy, failure, inflammation and ischemia. Dynamic or functional LP analysis during exercise testing, electrophysiological investigation or coronary angiophty may be a further application.

Key Words: Ventricular late potentials • principles and techniques • clinical application • risk stratification


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.